Document Detail

The role of gasotransmitters NO, H2 S, CO in myocardial ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
MedLine Citation:
PMID:  24923364     Owner:  NLM     Status:  Publisher    
Ischemic heart disease is one of the leading causes of morbidity and mortality worldwide. The development of cardioprotective therapeutic agents remains a partially unmet need and a challenge for both medicine and industry, with significant financial and social implications. Protection of the myocardium can be achieved by mechanical vascular occlusions such as preconditioning (PC) when brief episodes of ischemia/reperfusion are subjected prior to ischemia; postconditioning (PostC) when the brief episodes are subjected at the immediate onset of reperfusion, as well as remote conditioning (RC) when the brief episodes are subjected in another vascular territory. The elucidation of the signaling pathways which underlie the protective effects of PC, PostC and RC would be expected to reveal novel molecular targets for cardioprotection that could be manipulated by pharmacological agents to prevent reperfusion injury. Gasotransmitters including nitric oxide (NO), hydrogen sulphide (H2 S) and carbon monoxide (CO) are a growing family of regulatory molecules which impact on physiological and pathological functions. NO, H2 S and CO share several common properties; they are beneficial at low concentrations but hazardous in higher amounts, they relax smooth muscle cells, inhibit apoptosis, and exert anti-inflammatory effects. In the cardiovascular system, both NO, H2 S and CO induce vasorelaxation, and promote cardioprotection. In this review article, we summarize current knowledge on the role of the gasotransmitters NO, H2 S, and CO in myocardial ischemia/reperfusion injury and cardioprotection provided by conditioning strategies and highlight future perspectives in cardioprotection by NO, H2 S, CO, as well as their donor molecules.
Ioanna Andreadou; Efstathios K Iliodromitis; Tienush Rassaf; Rainer Schulz; Andreas Papapetropoulos; Péter Ferdinandy
Related Documents :
10732904 - Early postoperative changes in regional systolic and diastolic left ventricular functio...
16765234 - Postoperative outcomes for patients undergoing elective revascularization for critical ...
24108764 - Enoyl coenzyme a hydratase domain-containing 2, a potential novel regulator of myocardi...
7994804 - Long-term survival of medically treated patients in the coronary artery surgery study (...
1343454 - Late vascular complication after blunt trauma.
12383404 - The emerging role of induced hypothermia in the management of acute stroke.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-12
Journal Detail:
Title:  British journal of pharmacology     Volume:  -     ISSN:  1476-5381     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-6-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
This article is protected by copyright. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hepatocellular carcinoma based on cryptogenic liver disease -the most common hepatocellular carcinom...
Next Document:  Micropush-out dentine bond strength of a new gutta-percha and niobium phosphate glass composite.